A phase II immunochemotherapy study with alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (campath-FCD) in peripheral T-cell lymphomas

Weidmann, Eckhart and Hess, Georg and Krause, Stefan W. and Subklewe, Marion and Kruse, Judith and Soekler, Martin and Weisel, Katja and Kim, Soo-Zin and Dreyling, Martin H. and Jager, Elke (2006) A phase II immunochemotherapy study with alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (campath-FCD) in peripheral T-cell lymphomas. BLOOD, 108 (11): 2721. 769A. ISSN 0006-4971

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 04 Mar 2021 09:57
Last Modified: 04 Mar 2021 09:57
URI: https://pred.uni-regensburg.de/id/eprint/33765

Actions (login required)

View Item View Item